GlassScriptPhysician profile
Sarah Allene Stevenson
NPI 1386299584
$2,846.56
in general payments reported to CMS, 2019-2025
26 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $543 · 2023: $1,565 · 2024: $142 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512 · Travel and Lodging: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.49 |
| Travel and Lodging | $791.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,058.96 | 2023-2025 | Ams 700 Cxr Rte Kit, Ams 700, Rezum Generator |
| Abbvie INC. | $357.92 | 2022-2025 | |
| Astellas Pharma US INC | $211.09 | 2022-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $134.89 | 2023-2025 | Orgovyx, Gemtesa |
| Novo Nordisk INC | $100.57 | 2025 | Rivfloza |
| Olympus America INC. | $92.04 | 2023-2025 | Itind System |
| Urogen Pharma, INC. | $85.64 | 2023-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $80.41 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Dendreon Pharmaceuticals LLC | $78.55 | 2022-2024 | Provenge |
| Janssen Biotech, INC. | $78.12 | 2022-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $73.56 | 2022-2025 | |
| Tolmar, INC. | $65.33 | 2023-2025 | Eligard, Jatenzo |
| Medtronic, INC. | $65.22 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $55.81 | 2023 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $43.26 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $41.90 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Procept Biorobotics Corporation | $40.39 | 2025 | |
| Myriad Genetic Laboratories, INC. | $33.98 | 2022-2025 | Prolaris |
| Calyxo, INC. | $24.72 | 2025 | Cvac Aspiration System |
| Verity Pharmaceuticals INC. | $22.54 | 2023 | Trelstar |
| Blue Earth Diagnostics | $20.73 | 2024 | |
| Amgen INC. | $18.30 | 2022 | |
| Endo USA, INC. | $17.06 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $16.95 | 2023 | Xiaflex |
| Axonics, INC. | $15.03 | 2023 | Axonics |
| Sagent Pharmaceuticals | $13.59 | 2023 | Glydo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stevenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.